arsenic trioxide has been researched along with tetradecanoylphorbol acetate in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 7 (77.78) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gallagher, RE; Huang, XJ; Klein, RS; Wiernik, PH | 1 |
| Bruey, JM; Corcos, L; Garrido, C; Leroy, I; Lizard, G; Miguet, C; Plenchette, S; Rébé, C; Solary, E; Sordet, O | 1 |
| Aller, P; Amrán, D; de Blas, E; Fernández, C; Ramos, AM; Sancho, P | 1 |
| Fardel, O; Lemarie, A; Mérino, D; Micheau, O; Morzadec, C; Vernhet, L | 1 |
| Bai, J; Chen, H; Chen, R; Li, A; Liu, Z; Mao, W; Ye, J; Zhou, J | 1 |
| Cen, J; Chen, Z; Gu, M; Liu, D; Qi, X | 1 |
| Dölken, G; Greinacher, A; Jedlitschky, G; Kiefer, T; Köck, K; Kroemer, HK; Niessen, J; Oevermann, L; Ritter, CA; Scheitz, J; Siegmund, W; Starke, K; Zygmunt, M | 1 |
| An, R; Dong, X; Duan, G; Pan, S; Sun, X; Wang, Y | 1 |
| Fan, RH; Mi, RH; Wei, XD; Yin, QS; Yuan, FF; Zhang, XH | 1 |
9 other study(ies) available for arsenic trioxide and tetradecanoylphorbol acetate
| Article | Year |
|---|---|
Arsenic trioxide induces apoptosis of myeloid leukemia cells by activation of caspases.
Topics: Amino Acid Chloromethyl Ketones; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Caspase Inhibitors; Caspases; Enzyme Activation; Etoposide; Humans; Leukemia, Myeloid; Oxides; Signal Transduction; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1999 |
Mitochondria-targeting drugs arsenic trioxide and lonidamine bypass the resistance of TPA-differentiated leukemic cells to apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Caspases; Cell Differentiation; Cell-Free System; Drug Resistance; Etoposide; Humans; Indazoles; Leukemia; Mitochondria; Oxides; Proto-Oncogene Proteins c-bcl-2; Tetradecanoylphorbol Acetate; U937 Cells | 2001 |
12-O-tetradecanoylphorbol-13-acetate may both potentiate and decrease the generation of apoptosis by the antileukemic agent arsenic trioxide in human promonocytic cells. Regulation by extracellular signal-regulated protein kinases and glutathione.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Buthionine Sulfoximine; Cadmium Chloride; Caspase 3; Caspases; Dose-Response Relationship, Drug; Doxorubicin; Enzyme Activation; Enzyme Inhibitors; Glutathione; Humans; Immunoblotting; Mitogen-Activated Protein Kinases; Monocytes; Oxides; p38 Mitogen-Activated Protein Kinases; Protein Kinase C; Tetradecanoylphorbol Acetate; Time Factors; U937 Cells | 2004 |
Arsenic trioxide induces apoptosis of human monocytes during macrophagic differentiation through nuclear factor-kappaB-related survival pathway down-regulation.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Benzimidazoles; Blotting, Western; Carcinogens; Caspases; Cell Differentiation; Cell Survival; DNA; Down-Regulation; Endocytosis; Flow Cytometry; Fluorescent Dyes; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Macrophages; Monocytes; NF-kappa B; Oncogene Protein p65(gag-jun); Oxides; Phagocytosis; Reverse Transcriptase Polymerase Chain Reaction; RNA; Signal Transduction; Tetradecanoylphorbol Acetate; U937 Cells; X-Linked Inhibitor of Apoptosis Protein | 2006 |
JWA as a functional molecule to regulate cancer cells migration via MAPK cascades and F-actin cytoskeleton.
Topics: Actins; Amino Acid Motifs; Amino Acid Sequence; Arsenic Trioxide; Arsenicals; Base Sequence; Cell Movement; Cyclooxygenase 2; Cytoskeleton; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Focal Adhesion Kinase 1; Heat-Shock Proteins; HeLa Cells; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 1; MAP Kinase Signaling System; Membrane Transport Proteins; Mitogen-Activated Protein Kinases; Molecular Sequence Data; Neoplasms; Oxides; Phosphorylation; Protein Kinase C; Tetradecanoylphorbol Acetate | 2007 |
Expression of Dlk1 gene in myelodysplastic syndrome determined by microarray, and its effects on leukemia cells.
Topics: Adult; Aged; Antigens, CD34; Apoptosis; Arsenic Trioxide; Arsenicals; Calcium-Binding Proteins; Cell Cycle; Cell Proliferation; Female; Gene Expression Profiling; Gene Expression Regulation; Humans; Intercellular Signaling Peptides and Proteins; K562 Cells; Leukemia; Leukocytes, Mononuclear; Male; Membrane Proteins; Middle Aged; Myelodysplastic Syndromes; Oligonucleotide Array Sequence Analysis; Oxides; Tetradecanoylphorbol Acetate; Up-Regulation | 2008 |
Hematopoietic stem cell differentiation affects expression and function of MRP4 (ABCC4), a transport protein for signaling molecules and drugs.
Topics: Antigens, CD34; Arsenic Trioxide; Arsenicals; Base Sequence; Blotting, Western; Cell Differentiation; Cholecalciferol; DNA Primers; Flow Cytometry; Hematopoietic Stem Cells; Humans; Microscopy, Fluorescence; Multidrug Resistance-Associated Proteins; Oxides; Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Tetradecanoylphorbol Acetate | 2009 |
Protein kinase C is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in human bladder cancer cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Enzyme Activators; Humans; Oxides; Protein Kinase C; Protein Kinase Inhibitors; Signal Transduction; Tetradecanoylphorbol Acetate; Time Factors; Urinary Bladder Neoplasms | 2009 |
[Effects of As2O3 in combination with TPA on K562 cells].
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Cell Cycle; Drug Synergism; Humans; K562 Cells; Oxides; Tetradecanoylphorbol Acetate | 2014 |